Next big thing: The Miracle Pill - Panel discussion

01 May 2013

If a drug can improve an individual's performance, and does not create side-effects, would it be such a bad thing? Miracle pills are discussed by Dr Bennett Foddy, Deputy Director, Institute for Science and Ethics, Oxford Martin School; Dr Hilary Leevers, Head of Education and Learning, Wellcome Trust; Dr Anders Sandberg, James Martin Fellow, Oxford Martin Programme on the Impacts of Future Technology; Dr James Wilson, Lecturer in Philosophy and Health, University College London. This event was part of the Next Big Thing seminar series held in partnership with Nesta and Policy Exchange.